Helix Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform
Helix Platform Granted the 1st and Only FDA Authorization for a Whole Exome Sequencing Platform
Helix advises this marks the first time such a broad, sequencing-based device has been authorized by the FDA.